# Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency

> **NCT01787409** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mayo Clinic** · enrollment: 565 (actual)

## Conditions studied

- Aggressive Non-Hodgkin Lymphoma
- Anaplastic Large Cell Lymphoma
- Angioimmunoblastic T-Cell Lymphoma
- Chronic Lymphocytic Leukemia
- Diffuse Large B-Cell Lymphoma
- Enteropathy-Associated T-Cell Lymphoma
- Hepatosplenic T-Cell Lymphoma
- Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma
- Mediastinal (Thymic) Large B-Cell Lymphoma
- Nasal Type Extranodal NK/T-Cell Lymphoma
- Peripheral T-Cell Lymphoma, Not Otherwise Specified
- Primary Cutaneous Anaplastic Large Cell Lymphoma
- Refractory Anaplastic Large Cell Lymphoma
- Small Lymphocytic Lymphoma
- Subcutaneous Panniculitis-Like T-Cell Lymphoma

## Interventions

- **DIETARY_SUPPLEMENT:** Cholecalciferol
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT01787409
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2013-03-06
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 565 (ACTUAL)
- **Last updated:** 2025-12-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01787409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01787409, "Cholecalciferol in Improving Survival in Patients With Newly Diagnosed Cancer With Vitamin D Insufficiency". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01787409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*